e-learning
resources
Virtual 2020
Pre-Congress Content
Physiological and cellular mechanisms affecting pulmonary pathologies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of the kinase-dependent functions of RIPK1 in COPD
H. Van Eeckhoutte (Ghent, Belgium), Y. Dondelinger (Ghent, Belgium), T. Delanghe (Ghent, Belgium), P. Vandenabeele (Ghent, Belgium), G. Brusselle (Ghent, Belgium), M. Bertrand (Ghent, Belgium), K. Bracke (Ghent, Belgium)
Source:
Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Session:
Physiological and cellular mechanisms affecting pulmonary pathologies
Session type:
E-poster session
Number:
2586
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Van Eeckhoutte (Ghent, Belgium), Y. Dondelinger (Ghent, Belgium), T. Delanghe (Ghent, Belgium), P. Vandenabeele (Ghent, Belgium), G. Brusselle (Ghent, Belgium), M. Bertrand (Ghent, Belgium), K. Bracke (Ghent, Belgium). Role of the kinase-dependent functions of RIPK1 in COPD. 2586
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Role of IκB kinases (IKKs) α and β in severe asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 2s
Year: 2005
JAK–STAT pathway activation in COPD
Source: Eur Respir J 2015; 46: 843-845
Year: 2015
Inhibition of p38 mitogen-activated protein kinase has no effect on macrophage phagocytosis of bacteria in patients with COPD
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Role of p38 mitogen-activated protein kinase in trauma/hemorrhage and subsequent peumococcal pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Role of RhoA/Rho-kinase pathway in the regulation of eNOS activity in COPD patients
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
c-Jun N-terminal kinase-dependent mechanisms in respiratory disease
Source: Eur Respir J 2006; 28: 651-661
Year: 2006
Ventilation-induced activation of the mitogen-activated protein kinase pathway
Source: Eur Respir J 2002; 20: 946-956
Year: 2002
Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007
Pro-inflammatory role of the nuclear kinase MSK1 in asthma
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008
Role of c-Jun N-terminal kinase in human eosinophil apoptosis
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004
Activation of IL-32 pathway in COPD
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008
p38 MAP kinase mediates apoptosis related to ventilator associated lung injury
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
p38 MAPK inhibitors in COPD
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
Increased activation of p38 MAPK in COPD
Source: Eur Respir J 2008; 31: 62-69
Year: 2008
Involvement of NFkB activation and c-JUN phosphorylation in bronchial epithelial cells by CD-40-CD40L pathway
Source: Eur Respir J 2002; 20: Suppl. 38, 573s
Year: 2002
Inhibition of VEGF blocks the activation of TGF-β
1
through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
LSC - 2017 - Profibrotic signaling by TGF-ß involves NADPH oxidase 4 dependent activation of tyrosine kinase Src and mitochondrial ROS
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs
Source: Eur Respir J 2013; 42: 28-41
Year: 2013
In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis
Source: Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020
Year: 2020
The role of NRF-2 and p38 MAPK on the function of human parenchymal fibroblasts
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept